This article was first published on April 4, 2024. It was last reviewed, updated, or edited on April 5, 2024. Understandably, there is a huge interest in glucagon-like peptide-1 (GLP-1) receptor agonists among patients, medical professionals, and the general public. These medications produce greater weight loss in a high proportion of persons with obesity and…